Exo Lab
Innovating a new raw material based on plant-derived exosomes from Italian organic agriculture, aimed at revolutionizing nutraceutical and dermocosmetic products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | €5.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 1830 % | 441 % | 49 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (657 %) | (144 %) | (21 %) | (32 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Exo Lab Italia is a pioneering startup with over 20 years of research experience, specializing in the innovative use of Extracellular Vesicles (EVs). In the past five years, the company has focused its research on Plant-Derived Exosomes (PDEs) sourced from vegetables grown through Italian organic agriculture. Exo Lab Italia stands out as the first company globally to base its operations on the research, development, production, and marketing of products derived from plant exosomes.
The company operates in the biotechnology sector, specifically targeting industries that can benefit from its innovative raw materials. These industries include pharmaceuticals, cosmetics, and agriculture. Exo Lab Italia serves a diverse range of clients, from research institutions and pharmaceutical companies to cosmetic brands and agricultural firms.
Exo Lab Italia's business model revolves around creating and selling highly innovative raw materials derived from plant exosomes. The company also offers specialized consulting services tailored to the needs of its clients. By leveraging its extensive research and development capabilities, Exo Lab Italia generates revenue through the sale of its unique products and consulting services.
The company makes money by selling its plant-derived exosome products to various industries that require advanced, natural, and effective raw materials. Additionally, Exo Lab Italia provides consulting services to organizations looking to integrate these innovative materials into their products or research projects.
In summary, Exo Lab Italia is a trailblazing biotech company that leverages its expertise in plant-derived exosomes to create innovative products for multiple industries, thereby generating revenue through product sales and consulting services.
Keywords: Biotechnology, Plant Exosomes, Organic Agriculture, Research, Development, Pharmaceuticals, Cosmetics, Agriculture, Consulting Services, Innovation.